At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 306 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT05761093N/ARecruitingUpdate OverdueUpdated 13mo ago · Completion was 6mo agoEnrollment Stalled
Long Recruiting
Update Overdue
A Study to Evaluate Patient and Physician Benefit/ Risk Preferences for Treatment of Metastatic Prostate Cancer (mPC) in Hong Kong: a Discrete Choice Experiment
In Brief
An observational study for Prostate Cancer. Currently recruiting, targeting 306 participants across 1 site.
Signals
Enrollment appears stalled
Detailed Summary
The objective of this study is to examine the preference weightings in term of risk/ benefit attributes of treatment in physician and prostate cancer patients from different stages of disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesHong Kong
Collaborators--
Timeline
N/ARecruitingOverdue
2023202420252026
Enrollment StartSep 2022
First PostedMar 2023
Primary CompletionDec 2025
Study CompletionMar 2026
TodayJul 2026
First PostedMar 9, 2023
Enrollment StartSep 7, 2022
Primary CompletionDec 31, 2025
Study CompletionMar 31, 2026
TodayJul 1, 2026
Enrollment to primary: 3.3 yearsPosted 3.3 years ago